Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News C21 Investments Inc CXXIF


Primary Symbol: C.CXXI

Healthcare Cannabis Cannabis
C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk and packaged flowers; edibles; pre-rolls; tinctures; and topicals. It also provides... see more

Current News (CSE:CXXI)

C21 Investments Reports Third Quarter Financial Results

Canada NewsWire February 10, 2026

C21 Investments Announces Renewed Normal Course Issuer Bid

Newsfile December 5, 2025

C21 Investments Reports Second Quarter Financial Results

Canada NewsWire November 11, 2025

C21 Investments to Report Second Quarter Financial Results on November 11, 2025

Newsfile November 7, 2025

CSE Bulletin: MOC Eligibility Update

Newsfile October 14, 2025

C21 Investments Announces Completion of Non-Dilutive Creation and Issuance of Subordinate Voting Shares

Newsfile September 8, 2025

C21 Investments Announces Settlement of Eco Firma Farms Litigation

Newsfile September 4, 2025

C21 Investments Reports First Quarter Financial Results

Canada NewsWire July 31, 2025

C21 Investments Reports Fourth Quarter and Fiscal Year End Financial Results

Canada NewsWire June 23, 2025
View More News ››

Opinion & Analysis (CSE:CXXI)

VIDEO: C21 Investments: Large Revenue Projection for 2019

BTV-Business Television November 21, 2018

VIDEO: Largest Cannabis Dispensary in Nevada

BTV-Business Television November 2, 2018
View More Opinion ››

Bullboard Posts (CSE:CXXI)

RE:RE:Question for Mutley or anyone

Thank you Mutley.
hevin - 3 days ago

RE:Question for Mutley or anyone

So I have tried to find the breakdown but this information is not published.  However, this should not be a major issue soon. ...
MuttleyKnows - 3 days ago

Question for Mutley or anyone

It appears for now at least  that only medical cannabis will be given tax relief...does anyone know what percentage medical c21 does...
hevin - April 27, 2026

RE:RE:Rescheduling and beyond....

Also, it's a vertical company which grows it, then sells it in its own stores. And c21 actually increasing revenue while the overall...
hevin - April 22, 2026

RE:Rescheduling and beyond....

Mutley answers this nicely below....he estimates 3 million US per year we no longer have to pay in tax when the schedule 3 tax laws kick...
hevin - April 22, 2026

Rescheduling and beyond....

Geez this is a quiet board. Who can tell me the main catalysts / value propositions for this company outside of the broader Rescheduling...
barcodewhiz - April 20, 2026
View more Bullboard ››

NurExone Biologic

NurExone Biologic

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based ...
View More »

Podcasts